Načítá se...
Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
Morbidity due to respiratory syncytial virus (RSV) disease is still high in infants and children worldwide during the first two to five years of life. Certain categories of high-risk infants with increased morbidity and mortality attributed to RSV disease have been identified and are included in nat...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Open
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133922/ https://ncbi.nlm.nih.gov/pubmed/25132870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874285801408010071 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|